| NCT02210000 | Gastroparesis | Phase 2 | Completed | - | - |
| NCT01466335 | Bone Marrow Transplantation | Phase 1 | Completed | - | United States, New York
... more >>
GSK Investigational Site
Buffalo, New York, United States, 14202 Collapse << |
| NCT02210000 | - | - | Completed | - | - |
| NCT01602549 | Gastroparesis | Phase 2 | Completed | - | Australia, New South Wales
... more >>
GSK Investigational Site
Randwick, New South Wales, Australia, 2031
Germany
GSK Investigational Site
Ulm, Baden-Wuerttemberg, Germany, 89081
GSK Investigational Site
Bochum, Nordrhein-Westfalen, Germany, 44791
GSK Investigational Site
Bonn, Nordrhein-Westfalen, Germany, 53105
GSK Investigational Site
Koeln, Nordrhein-Westfalen, Germany, 50937
GSK Investigational Site
Jena, Thueringen, Germany, 07747
GSK Investigational Site
Berlin, Germany, 13088
Sweden
GSK Investigational Site
Uppsala, Sweden, SE-751 85
United Kingdom
GSK Investigational Site
Cambridge, United Kingdom, C2B 2PY
GSK Investigational Site
Newcastle Upon Tyne, United Kingdom, NE4 5PL
GSK Investigational Site
Norwich, United Kingdom, NR4 7UY Collapse << |
| NCT01934192 | Gastroparesis | Phase 2 | Terminated | - | United States, Colorado
... more >>
GSK Investigational Site
Aurora, Colorado, United States, 80045
United States, Georgia
GSK Investigational Site
Augusta, Georgia, United States, 30909
United States, Kentucky
GSK Investigational Site
Louisville, Kentucky, United States, 40202
United States, Pennsylvania
GSK Investigational Site
Philadelphia, Pennsylvania, United States, 19104
Australia, New South Wales
GSK Investigational Site
Randwick, New South Wales, Australia, 2031
Australia, Queensland
GSK Investigational Site
Southport, Queensland, Australia, 4215
Australia, South Australia
GSK Investigational Site
Adelaide, South Australia, Australia, 5000
GSK Investigational Site
Woodville, South Australia, Australia, 5011
Canada, Alberta
GSK Investigational Site
Calgary, Alberta, Canada, T1Y 6J4
GSK Investigational Site
Calgary, Alberta, Canada, T2N 2T9
Canada, Ontario
GSK Investigational Site
Hamilton, Ontario, Canada, L8L 2X2
GSK Investigational Site
Kingston, Ontario, Canada, K7L 2V7
GSK Investigational Site
Ottawa, Ontario, Canada, K1H 8L6
GSK Investigational Site
Ottawa, Ontario, Canada, K1Y 4E9
GSK Investigational Site
Toronto, Ontario, Canada, M5G 1X5
Canada, Quebec
GSK Investigational Site
Montreal, Quebec, Canada, H2X 3J4
GSK Investigational Site
Sainte-Foy, Quebec, Canada, G1V 4G5
GSK Investigational Site
Sherbrooke, Quebec, Canada, J1H 5N4
Canada
GSK Investigational Site
Quebec, Canada, G1J 1Z4 Collapse << |
| NCT01366560 | Gastrointestinal Motility | Phase 1 | Completed | - | United Kingdom
... more >> GSK Investigational Site
Cambridge, United Kingdom, CB2 2GG Collapse << |
| NCT00562848 | Gastroparesis | Phase 1 | Completed | - | Belgium
... more >> GSK Investigational Site
Leuven, Belgium, 3000 Collapse << |
| NCT01267071 | Gastroparesis | Phase 1 | Completed | - | United Kingdom
... more >> GSK Investigational Site
Nottingham, United Kingdom, NG11 6JS Collapse << |
| NCT01602549 | - | - | Completed | - | - |
| NCT00861809 | Gastroparesis | Phase 2 | Completed | - | Belgium
... more >> GSK Investigational Site
Leuven, Belgium, 3000
Sweden
GSK Investigational Site
Stockholm, Sweden, SE-171 76 Collapse << |
| NCT01039805 | Gastroparesis | Phase 2 | Completed | - | Australia, South Australia
... more >>
GSK Investigational Site
Adelaide, South Australia, Australia, 5000 Collapse << |
| NCT00733551 | Gastroparesis | Phase 1 | Completed | - | United Kingdom
... more >> GSK Investigational Site
Cambridge, Cambridgeshire, United Kingdom, CB2 2GG Collapse << |
| NCT01039974 | Gastroparesis | Phase 1 | Completed | - | United States, New York
... more >>
GSK Investigational Site
Buffalo, New York, United States, 14202 Collapse << |
| NCT01934192 | - | - | Terminated | - | - |
| NCT01262898 | - | - | Completed | - | - |
| NCT01262898 | Gastroparesis | Phase 2 | Completed | - | - |
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
